Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIR
查看详细走势图
0.140USD
-0.010-6.47%
收盘 12/10, 16:00（美东）报价延迟15分钟
--总市值
--市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-6.47%
5天
0.00%
1月
0.00%
6月
0.00%
今年开始到现在
0.00%
1年
0.00%
查看详细走势图
TradingKey股票评分
由于缺少必要的数据，暂不能对该公司进行评分
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030简介
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
公司代码DMIIR
公司Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
CEOStockwell (Lynn)
网址
常见问题
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的当前股价是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的当前股价是 0.140。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的股票代码是什么？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的股票代码是DMIIR。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52周最高点是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52周最高点是0.170。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52周最低点是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030股票的52周最低点是0.140。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的市值是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的市值是--。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的净利润是多少？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的净利润为--。
现在Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的股票是买入、持有还是卖出？
根据分析师评级，Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)的总体评级为--，目标价格为--。
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)股票的每股收益（EPS TTM）是多少
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030(DMIIR)股票的每股收益（EPS TTM）是--。
